{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:56:49Z","timestamp":1790362609008,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clinthera.2024.08.006","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:14:12Z","timestamp":1726485252000},"page":"870-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics and Pharmacodynamics of a Fixed-Dose Combination of Esomeprazole and Magnesium Hydroxide Compared to the Enteric-Coated Esomeprazole"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2141-2407","authenticated-orcid":false,"given":"Yoonjin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungyeun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inseung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1713-9194","authenticated-orcid":false,"given":"SeungHwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinthera.2024.08.006_bib0001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2024.08.006_bib0002","first-page":"S49","article-title":"Management strategies for gastroesophageal reflux disease","volume":"19","author":"Bak","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.clinthera.2024.08.006_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102043","article-title":"Formulation of dosage forms with proton pump inhibitors: state of the art, challenges and future perspectives","volume":"14","author":"Srebro","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clinthera.2024.08.006_bib0004","article-title":"Refractory gastroesophageal reflux disease: a management update","volume":"8","author":"Rettura","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.clinthera.2024.08.006_bib0005","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1365-2036.2001.01087.x","article-title":"Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole","volume":"15","author":"Andersson","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2024.08.006_bib0006","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.2147\/DDDT.S341271","article-title":"Comparative pharmacokinetics\/pharmacodynamics of fixed-dose combination of esomeprazole and calcium carbonate (AD-206) to the conventional esomeprazole","volume":"15","author":"Bae","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clinthera.2024.08.006_bib0007","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.2147\/DDDT.S212491","article-title":"The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg\/sodium bicarbonate 800 mg in healthy adult male","volume":"13","author":"Kim","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.006_bib0008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00424-008-0495-4","article-title":"The gastric HK-ATPase: structure, function, and inhibition","volume":"457","author":"Shin","year":"2009","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.clinthera.2024.08.006_bib0009","unstructured":"The Korean Ministry of Food and Drug Safety (MFDS). Bioequivalence test review results of Hanxium\u00ae. 2014;"},{"key":"10.1016\/j.clinthera.2024.08.006_bib0010","unstructured":"The Korean Ministry of Food and Drug Safety (MFDS). Bioequivalence test review results of Esora\u00ae. 2016;"},{"key":"10.1016\/j.clinthera.2024.08.006_bib0011","unstructured":"The Korean Ministry of Food and Drug Safety (MFDS). Bioequivalence test review results of S-Empra\u00ae. 2016;"},{"issue":"234","key":"10.1016\/j.clinthera.2024.08.006_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/003655201753265389","article-title":"Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality","volume":"36","author":"Kromer","year":"2001","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"10 Pt 2","key":"10.1016\/j.clinthera.2024.08.006_bib0013","first-page":"74S","article-title":"Pharmacologic properties of proton pump inhibitors","volume":"23","author":"Welage","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2024.08.006_bib0014","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2036.2005.02709.x","article-title":"Review article: immediate-release proton-pump inhibitor therapy\u2014potential advantages","volume":"22","author":"Howden","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221086457","article-title":"Antacids revisited: review on contemporary facts and relevance for self-management","volume":"50","author":"Garg","year":"2022","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinthera.2024.08.006_bib0016","doi-asserted-by":"crossref","unstructured":"Porter S, Sackett G, Liu L. Chapter 34 - Development, Optimization, and Scale-Up of Process Parameters: Pan Coating, Editor(s): Yihong Qiu, Yisheng Chen, Geoff G.Z. Zhang, Lawrence Yu, Rao V. Mantri, Developing Solid Oral Dosage Forms (Second Edition), Academic Press, 2017, 953-996, https:\/\/doi.org\/10.1016\/B978-0-12-802447-8.00034-0.","DOI":"10.1016\/B978-0-12-802447-8.00034-0"},{"issue":"1","key":"10.1016\/j.clinthera.2024.08.006_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","volume":"19","author":"Shin","year":"2013","journal-title":"J Neurogastroenterol Motil"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.006_bib0018","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2036.2002.01158.x","article-title":"Integrated acidity and rabeprazole pharmacology","volume":"16","author":"Gardner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.clinthera.2024.08.006_bib0019","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1542-3565(05)00023-6","article-title":"Early heartburn relief with proton pump inhibitors: a systematic review and meta-analysis of clinical trials","volume":"3","author":"McQuaid","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.006_bib0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1572-0241.2001.03600.x","article-title":"Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial","volume":"96","author":"Richter","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinthera.2024.08.006_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 Years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"issue":"9-10","key":"10.1016\/j.clinthera.2024.08.006_bib0022","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s002280000206","article-title":"Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects","volume":"56","author":"Hassan-Alin","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.clinthera.2024.08.006_bib0023","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003088-200140060-00003","article-title":"Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole","volume":"40","author":"Andersson","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2024.08.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/2042098618809927","article-title":"The risks of long-term use of proton pump inhibitors: a critical review","volume":"10","author":"Jaynes","year":"2019","journal-title":"Ther Adv Drug Saf"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T01:02:49Z","timestamp":1732410169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824002194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0149291824002194"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.08.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and Pharmacodynamics of a Fixed-Dose Combination of Esomeprazole and Magnesium Hydroxide Compared to the Enteric-Coated Esomeprazole","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}